Literature DB >> 17551954

Left atrium myxosarcoma: an exceptional cardiac malignant primary tumor.

Paula Awamleh1, M Teresa Alberca, Carlos Gamallo, Santos Enrech, Anas Sarraj.   

Abstract

We report the case of a 32-year-old patient with a left atrium myxosarcoma, presenting with congestive heart failure. It is a rare cardiac malignant primary tumor that seems to derive from the same cellular line as myxomas, but the prognosis is very different. These tumors present local recidives and distance metastasis, so the mean survival is about 1 year, independent of any therapeutical option.

Entities:  

Mesh:

Year:  2007        PMID: 17551954      PMCID: PMC6653250          DOI: 10.1002/clc.20045

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  5 in total

1.  Surgical treatment of cardiac tumors: a 5-year experience from a single cardiac center.

Authors:  Liang Yin; Dengke He; Hua Shen; Xinyu Ling; Wei Li; Qian Xue; Zhinong Wang
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

2.  Surgical treatment of cardiac myxosarcoma.

Authors:  Masato Suzuki; Hirosato Doi; Ryuji Koshima; Kenji Sugiki; Teruhisa Kazui; Takemi Ohno
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-04-12

Review 3.  Multidetector CT and MR imaging of cardiac tumors.

Authors:  Eun Young Kim; Yeon Hyeon Choe; Kiick Sung; Seung Woo Park; Ji Hye Kim; Young-Hyeh Ko
Journal:  Korean J Radiol       Date:  2009-03-03       Impact factor: 3.500

4.  Surgery Treatment Improved the Overall Survival Rate in Locoregional Myxoid Leiomyosarcoma than Other Myxosarcomas in the United States.

Authors:  Marwan Almoiliqy; Abdullah Al-Danakh; Mohammed Safi; Mohammed Alradhi; Mahmoud Al-Azab; Salah Adlat; Wanhai Zhou; Aiman Saleh A Mohammed; Ahmed Al-Maamari
Journal:  Oxid Med Cell Longev       Date:  2021-04-30       Impact factor: 6.543

5.  Primary Cardiac High-grade Myxofibrosarcoma Presenting with Multiple Brain Metastases: A Case Report.

Authors:  Filippo Badaloni; Eugenio Pozzati; Gianluca Marucci; Pietro Fiaschi; Antonio Fioravanti
Journal:  Cureus       Date:  2017-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.